Squamous histology
Showing 1 - 25 of 3,348
NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Durvalumab
- +5 more
- (no location specified)
Aug 17, 2023
Nivolumab in Locally Advanced or Metastatic Non-Small Cell Lung
Recruiting
- Non-Small Cell Lung Cancer
-
Athens, GreeceLocal Institution
Aug 31, 2021
Ex-vivo Examination of Excisions of Skin Tumors by Confocal
Recruiting
- Cutaneous Tumor
- +4 more
- Confocal optical coherence tomography - OCTAVE
-
Antony, IDF, FranceHôpital Privé d'Antony Antony
Apr 15, 2022
Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,
Not yet recruiting
- Bladder Squamous Cell Carcinoma
- +10 more
- Biospecimen Collection
- +5 more
-
Atlanta, Georgia
- +3 more
Feb 20, 2023
Bladder Adenocarcinoma, Bladder Mixed Adenocarcinoma, Bladder Squamous Cell Carcinoma Trial in Palo Alto (drug, procedure,
Active, not recruiting
- Bladder Adenocarcinoma
- +11 more
- Carboplatin
- +7 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Mar 25, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
GIOTRIF rPMS in Korean Patients With NSCLC
Completed
- Carcinoma, Non-Small-Cell Lung
- GIOTRIF 20mg
- +2 more
-
Multiple Locations, Korea, Republic of(unnamed)
Feb 5, 2021
NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)
Not yet recruiting
- NSCLC Stage IV
- +4 more
- Nivolumab and Ipilimumab
-
Verona, Veneto/Verona, ItalyCentro Ricerche Cliniche
Oct 26, 2022
Lung Non-Small Cell Squamous Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (Berzosertib, Carboplatin,
Recruiting
- Lung Non-Small Cell Squamous Carcinoma
- Stage IV Lung Cancer AJCC v8
- Berzosertib
- +6 more
-
Los Angeles, California
- +34 more
Jan 20, 2023
Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology Trial in Guangzhou, Beijing (BKM120)
Completed
- Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology
-
Guangzhou, Guangdong, China
- +2 more
Dec 6, 2020
Squamous NSCLC, Non-Squamous NSCLC Trial (Durvalumab, Tremelimumab)
Withdrawn
- Squamous Non-small Cell Lung Cancer
- Non-Squamous Non-small Cell Lung Cancer
- (no location specified)
Dec 17, 2021
Soluble Mediators, Cytokines, and Circulating Angiogenic Factors
Active, not recruiting
- Non-small Cell Lung Cancer
-
Elche, Alicante, Spain
- +24 more
Nov 8, 2022
Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Basal Cell Carcinoma of Skin
- microscopy confocal (Histolog Scanner)
-
Vandœuvre-lès-Nancy, FranceGilles Dolivet
Jul 7, 2023
NSCLC Trial (Zimberelimab, Domvanalimab, Pembrolizumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- Zimberelimab
- +7 more
- (no location specified)
Aug 12, 2022
Does Cryofixation of Skin Specimens Affect Quality of Subsequent
Completed
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
-
Philadelphia, PennsylvaniaAbramsonc Cancer Center of the University of Pennsylvania
Jul 29, 2019
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Tucson, Arizona
- +52 more
Oct 13, 2022
Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node
Recruiting
- Squamous Cell Carcinoma
- +2 more
- sentinel lymph node biopsy (SLNB)
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 15, 2022
Nasal Vestibule Carcinoma, Rhinectomy, Nasal Vestibule Trial in France, Italy, United Kingdom (Rhinectomy)
Recruiting
- Nasal Vestibule Carcinoma
- +3 more
- Rhinectomy
-
Toulouse, Touluse, France
- +5 more
Jan 11, 2023
Therapy Using 18F-FSPG PET
Not yet recruiting
- Cancer
- +3 more
- 18F-FSPG PET/CT in NSCLC
- 18F-FSPG PET/CT in HNSCC
- (no location specified)
May 24, 2023
NSCLC Trial in Tampa, Chapel Hill, Durham (Thoracic Radiotherapy, Platinum Based Chemotherapy, Ipilimumab)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Thoracic Radiotherapy
- +3 more
-
Tampa, Florida
- +2 more
Sep 30, 2022
Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer Trial (Zimberelimab (ZIM), Domvanalimab (DOM), Sacituzumab
Not yet recruiting
- Lung Cancer
- Advanced or Metastatic Non-Small-Cell Lung Cancer
- Zimberelimab (ZIM)
- +9 more
- (no location specified)
Nov 21, 2022
Solid Tumor, Adult, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (AVID100 IV)
Terminated
- Solid Tumor, Adult
- +3 more
- AVID100 IV
-
New Haven, Connecticut
- +9 more
Mar 22, 2021
A Multicenter Cancer Biospecimen Collection Study
Recruiting
- Cancer of Head and Neck
- +10 more
- OncoPrism™ assay
-
San Francisco, CaliforniaCurebase
Mar 8, 2022
Cervix Cancer, HPV Infection, Cervical High Grade Squamous Intraepithelial Lesion Trial in São Paulo, Cuernavaca (Xpert HPV, S5
Recruiting
- Cervix Cancer
- +3 more
- Xpert HPV
- S5 DNA methylation classifier
-
São Paulo, Brazil
- +1 more
Aug 14, 2023